Open original FDA record ↗Recall record
- FDA identifier
- Z-1760-2025
- Company in FDA record
- Centerline Biomedical Inc
- FDA classification date
- May 19, 2025
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class I
Reason stated in the source
Centerline Biomedical has determined that the coating on the guidewires for lot 2404-2005 may delaminate during use of the guidewire.
Source facts
- Action
- Centerline Biomedical issued an "URGENT MEDICAL DEVICE RECALL" notice dated 4/11/2025 to its consignees on 04/11/2025 via hand delivery. The notice explained the issue with the device, potential risk to the patient and actions to be taken. The consignees were requested to Complete the Customer Acknowledgement letter in the possession of your Clinical Account Manager and return all affected products to Clinical Account Manager. For questions contact: Director Quality and Regulatory, Phone Number: (330) 577-5033, Email: kevin.reed@centerlinebiomedical.com.
- Initiated
- 2025-04-11
- Root cause
- Under Investigation by firm
- Distribution
- US distribution to states of: Pennsylvania, Florida, Texas, New York, North Carolina, New Mexico, Virginia, Tennessee
- Recall number
- Z-1760-2025
- Recall status
- Open, Classified
- CDRH record ID
- 213421
- FDA classified
- 2025-05-19
- Recall event number
- 96697